Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ARS Pharmaceuticals, Inc.
| Metric | ARS Pharmaceuticals, Inc. SPRYHealthcare |
|---|---|
| Quality Score | 37 / 100 |
| Revenue (latest) | $84M |
| Net income (latest) | −$171M |
| Operating margin | −212.9% |
| Net margin | −203.3% |
| Return on equity | −149.9% |
| Return on assets | −52.3% |
| Return on capital (ROCE) | −62.2% |
| Debt / equity | 1.87× |
| Revenue growth (YoY) | −5.5% |
| Altman Z″ (distress) | -1.13 |
| Accruals / assets | −0.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.